Your browser doesn't support javascript.
loading
Comparison of S-1-cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials.
Kawakami, Hisato; Fujitani, Kazumasa; Matsuyama, Jin; Akamaru, Yusuke; Tamura, Shigeyuki; Endo, Shunji; Kimura, Yutaka; Makari, Youichi; Tamura, Takao; Sugimoto, Naotoshi; Sakai, Daisuke; Tsujinaka, Toshimasa; Goto, Masahiro; Kurokawa, Yukinori; Shimokawa, Toshio; Satoh, Taroh.
Afiliación
  • Kawakami H; Department of Medical Oncology, Faculty of Medicine, Kindai University, 377-2 Ohno-higashi, Osaka-sayama, Osaka, 589-8511, Japan. kawakami_h@med.kindai.ac.jp.
  • Fujitani K; Department of Surgery, Osaka Prefectural General Medical Center, Osaka-shi, Japan.
  • Matsuyama J; Department of Gastroenterological Surgery, Higashiosaka City Medical Center, Higashiosaka, Japan.
  • Akamaru Y; Department of Surgery, Ikeda Municipal Hospital, Ikeda, Japan.
  • Tamura S; Department of Surgery, Yao Municipal Hospital, Yao, Japan.
  • Endo S; Department of Surgery, Faculty of Medicine, Kindai University, Osaka-sayama, Japan.
  • Kimura Y; Department of Surgery, Sakai City Medical Center, Sakai, Japan.
  • Makari Y; Department of Medical Oncology, Kindai University Nara Hospital, Ikoma, Japan.
  • Tamura T; Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Sugimoto N; Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan.
  • Sakai D; Cancer Center, Izumi City General Hospital, Izumi, Japan.
  • Tsujinaka T; Cancer Chemotherapy Center, Osaka Medical College Hospital, Takatsuki, Japan.
  • Goto M; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan.
  • Kurokawa Y; Clinical Study Support Center, Wakayama Medical University, Wakayama, Japan.
  • Shimokawa T; Department of Gastroenterological Surgery, Osaka University Graduate School of Medicine, Suita, Japan.
  • Satoh T; Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan.
Int J Clin Oncol ; 25(9): 1635-1643, 2020 Sep.
Article en En | MEDLINE | ID: mdl-32494981
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Protocolos de Quimioterapia Combinada Antineoplásica / Cisplatino Tipo de estudio: Clinical_trials Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Clin Oncol Asunto de la revista: NEOPLASIAS Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Japón